Chemical industry – Page 63
-
BusinessIndia hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
-
BusinessUS tax rules force fertiliser merger to fall flat
CF Industries’ $8bn merger plan to relocate from US to Europe scuppered by regulatory changes
-
BusinessUS tax relief law benefits chemical makers
Bill provides mechanism to waive import tariffs on materials not available from domestic suppliers
-
BusinessMonsanto turns down Bayer offer
As global agrochemical companies consolidate, Monsanto rejects ‘inadequate’ $62bn offer from Bayer
-
BusinessWHO clarifies glyphosate risks
UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels
-
-
BusinessMylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
-
BusinessPfizer to buy Anacor for eczema ointment
$5.2bn deal will bolster pharma giant’s inflammation and immunology drugs portfolio
-
Business
Honeywell spins off resins and chemicals unit
‘AdvanSix’ will separate by early 2017 and produce nylon, fertiliser and various chemical intermediates
-
NewsInsider trading scandal topples head of Taiwan’s top research body
President of umbrella organisation overseeing 24 research institutions caught up in investigation into offloading of biotech shares prior to poor results
-
Business
Total to buy Saft for battery boost
€950m deal pushes French oil giant deeper into renewables
-
BusinessDeadly US fertiliser plant blast was deliberately set
Fire that caused West Fertilizer explosion was a ‘criminal act,’ US agency concludes
-
BusinessEvonik acquires Air Products’ chemical unit
Air Products also spinning off electronic materials to focus on industrial gases
-
BusinessRethinking herbicide regulations
Europe withdraws amitrole and isoproturon, while EU, US and Colombia reconsider glyphosate rulings
-
-
BusinessDaiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
BusinessAbbot boosts heart devices with St Jude buyout
Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger
-
BusinessCancer deals spread
AbbVie nabs antibody specialist Stemcentrx, while Sanofi pursues Medivation
-
BusinessChemours sheds disinfectants and aniline
Dow Chemical and Germany’s Lanxess will buy plants as Chemours restructures following its spin-off from DuPont
-
BusinessPumping up industrial wasted heat
Company profile: Qpinch reclaims wasted energy by mimicking nature